BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9198207)

  • 21. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.
    Boers GH; Smals AG; Trijbels FJ; Fowler B; Bakkeren JA; Schoonderwaldt HC; Kleijer WJ; Kloppenborg PW
    N Engl J Med; 1985 Sep; 313(12):709-15. PubMed ID: 4033695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteinemia: new information about an old risk factor for vascular disease.
    Engman M
    J Insur Med; 1998; 30(4):231-6. PubMed ID: 10537928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of hyperhomocysteinaemia in cardiovascular disease.
    Lievers KJ; Kluijtmans LA; Blom HJ
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia and venous thrombosis.
    Bos GM; den Heijer M
    Semin Thromb Hemost; 1998; 24(4):387-91. PubMed ID: 9763356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperhomocysteinemia as a risk factor for vascular diseases].
    Ziegler R
    Med Monatsschr Pharm; 2006 Jun; 29(6):228-9. PubMed ID: 16792202
    [No Abstract]   [Full Text] [Related]  

  • 30. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
    Gábor D; Hrnciar J; Hricová I; Zacharová M
    Vnitr Lek; 1999 Jan; 45(1):40-5. PubMed ID: 10422525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can blood homocysteine explain the family history of vascular diseases?].
    Reis RP; Gomes E; Duarte R; Correia MJ; Cândido A; Reis HP; Azinheira J; Pina JE; Correia JM; Luís AS
    Rev Port Cardiol; 2001 Apr; 20(4):413-8. PubMed ID: 11433886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia and thrombosis: acquired conditions.
    Selhub J; D'Angelo A
    Thromb Haemost; 1997 Jul; 78(1):527-31. PubMed ID: 9198209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
    Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine: a new risk factor for atherosclerosis.
    Fallest-Strobl PC; Koch DD; Stein JH; McBride PE
    Am Fam Physician; 1997 Oct; 56(6):1607-12, 1615-6. PubMed ID: 9351429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
    Parnetti L; Caso V; Santucci A; Corea F; Lanari A; Floridi A; Conte C; Bottiglieri T
    Neurol Sci; 2004 Apr; 25(1):13-7. PubMed ID: 15060810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
    Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical relevance of homocysteine monitoring in the diabetic patient].
    Benmerabet S; Fredenrich A; Robillon JF; Canivet B; Candito M; Van Obberghen E
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):510-5. PubMed ID: 12522334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.